Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Artificial intelligence reveals hidden fluid flow patterns in sleeping brains

Artificial intelligence reveals hidden fluid flow patterns in sleeping brains

Virtual reality navigation deficits predict future brain volume loss

Virtual reality navigation deficits predict future brain volume loss

New study tests vitamin D analog against pancreatic cancer

New study tests vitamin D analog against pancreatic cancer

Estrogen decline alters brain cell matrix in older females

Estrogen decline alters brain cell matrix in older females

Gum disease pathogen may drive Alzheimer’s through microglial ferroptosis pathway

Gum disease pathogen may drive Alzheimer’s through microglial ferroptosis pathway

New study reveals nitric oxide’s widespread impact on genetics

New study reveals nitric oxide’s widespread impact on genetics

Disrupted sleep rhythms may increase dementia risk through impaired waste clearance

Disrupted sleep rhythms may increase dementia risk through impaired waste clearance

New immuno-infrared sensor aids in early diagnosis of Alzheimer’s and Parkinson’s disease

New immuno-infrared sensor aids in early diagnosis of Alzheimer’s and Parkinson’s disease

Common vegetable oil compound shows power to fight dangerous viruses

Common vegetable oil compound shows power to fight dangerous viruses

New study shows how exercise hormone reduces multiple sclerosis symptoms

New study shows how exercise hormone reduces multiple sclerosis symptoms

Uneven grey matter loss serves as a powerful new biomarker for early neurodegeneration

Uneven grey matter loss serves as a powerful new biomarker for early neurodegeneration

Key neural circuit helps the brain “change gears”

Key neural circuit helps the brain “change gears”

Researchers uncover new genetic links influencing blood lipid composition

Researchers uncover new genetic links influencing blood lipid composition

Women may face greater cognitive impact from dementia risk factors

Women may face greater cognitive impact from dementia risk factors

Researchers use living human cells on a chip to study memory loss

Researchers use living human cells on a chip to study memory loss

Popular analysis technique hides patient variability in Alzheimer's drug trials

Popular analysis technique hides patient variability in Alzheimer's drug trials

Low-frequency ultrasound waves directly manipulate blood flow properties

Low-frequency ultrasound waves directly manipulate blood flow properties

Discovery of memory switch in the brain opens new avenues for dementia therapies

Discovery of memory switch in the brain opens new avenues for dementia therapies

Sleep complaints highlight Alzheimer's risk in genetically predisposed women

Sleep complaints highlight Alzheimer's risk in genetically predisposed women

Blood metabolite patterns could reveal dementia risk in midlife

Blood metabolite patterns could reveal dementia risk in midlife

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.